Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Documentation regarding ANFH2 is limited primarily due to its rarity and the recent identification of its genetic basis. Because this condition affects a small population, systematic clinical studies have been sparse, leading to gaps in comprehensive clinical characterization. This situation can be frustrating, but ongoing research may provide more insights in the future.
The hallmark clinical feature of avascular necrosis of the femoral head, primary, 2 is avascular necrosis of the capital femoral epiphysis. This condition can lead to joint pain and mobility issues, particularly in the hip region. While the prevalence is not well characterized, the consistent presence of this phenotype suggests a significant impact on the affected individuals' quality of life.
To navigate ANFH2, consider consulting with an orthopedic specialist who has experience in managing avascular necrosis. Genetic counseling may also be beneficial to understand the implications of the TRPV4 gene variant for you and your family. While there are currently no identified patient organizations for ANFH2, you can explore resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for further information and support. Engaging with a genetic counselor can help you assess family planning options and potential genetic testing.
Actionable guidance for navigating care for avascular necrosis of femoral head, primary, 2
To navigate ANFH2, consider consulting with an orthopedic specialist who has experience in managing avascular necrosis. Genetic counseling may also be beneficial to understand the implications of the TRPV4 gene variant for you and your family. While there are currently no identified patient organizations for ANFH2, you can explore resources such as the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov for further information and support. Engaging with a genetic counselor can help you assess family planning options and potential genetic testing.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.